Verapamil selectively inhibits expression of interleukin-2 messenger RNA in mitogen activated mononuclear blood cells.
Zanker
B
B
Charles A. Dana Research Institute, Boston, MA.
Walz
G
G
Wieder
K J
KJ
Moscovitch-Lopatin
M
M
Smith
B R
BR
Strom
T B
TB
D002118:Calcium / Q000097:blood; D002478:Cells, Cultured; D003600:Cytosol / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D005796:Genes / Q000187:drug effects; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics*; D008213:Lymphocyte Activation; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014158:Transcription, Genetic / Q000187:drug effects*; D014700:Verapamil / Q000494:pharmacology*
D007376:Interleukin-2; D012333:RNA, Messenger; D014700:Verapamil; D002118:Calcium